Director of Medical Marketing & KOL Strategy

Definium Therapeutics is a late-stage biopharmaceutical company focused on psychedelics for psychiatric and neurological disorders. Headquartered in New York and publicly traded on Nasdaq, the company fosters a culture of relentless innovation and collaboration.
The Lead, Strategic Medical Marketing will guide the commercial launch of DT120 by coordinating with Medical Affairs, Regulatory, Commercial and Clinical Development, shaping KOL engagement and congress activities.

#J-18808-Ljbffr